Analysts Set Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Target Price at $39.81
Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) has been given an average rating of “Moderate Buy” by the seventeen analysts that are presently covering the firm, MarketBeat.com reports. Eight investment analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1 year […]
Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) has been given an average rating of “Moderate Buy” by the seventeen analysts that are presently covering the firm, MarketBeat.com reports. Eight investment analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1 year […]
